A Prospective Observational Study of Comparison, Safety, and Efficacy of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus in A Tertiary Care Hospital. Asian Journal of Pharmaceutical and Health Sciences, [S. l.], v. 12, n. 4, p. 2729–2738, 2022. DOI: 10.5530/ezagjy22. Disponível em: https://www.ajphs.com/index.php/ajphs/article/view/163. Acesso em: 7 oct. 2025.